Effect of Terminalia arjuna extract on adriamycin-induced DNA damage

Phytotherapy Research

Volumn 22, Issue 9, 2008, Pages 1188-1194

  Reddy, Tiyyagura Koti ^a   Seshadri, Prabhu ^a   Reddy, K Kodanda Rami ^a   Jagetia, G C ^b   Reddy, C Damodar ^a,c  

^a Sugen Life Sciences   (India)

^b MIZORAM UNIVERSITY   (India)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adriamycin; DNA damage and antioxidants; Free radicals; Micronuclei; Terminalia arjuna

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; ANTIOXIDANT; DOXORUBICIN; HYDROXYL RADICAL; OXYGEN RADICAL; SUPEROXIDE; TERMINALIA ARJUNA EXTRACT;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; DNA DAMAGE; DOSE RESPONSE; HUMAN; HUMAN CELL; MICRONUCLEUS; PERIPHERAL LYMPHOCYTE;

ANTINEOPLASTIC AGENTS; CELLS, CULTURED; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; FREE RADICAL SCAVENGERS; HUMANS; MICRONUCLEUS TESTS; PLANT EXTRACTS; TERMINALIA;

TERMINALIA ARJUNA;

EID: 52649144834     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2428     Document Type: Article

References (44)

1. Al-Harbi MM. 1993. Effect of captopril on the cytological and biochemical changes induced by adriamycin. Food Chem Toxicol 31: 209-212.
2. AM A, Kaur G, Hayat K, AN M, Ather M. 2003. A novel naphthanol glycoside from Terminalia arjuna with antioxidant and nitric oxide inhibitory activities. Pharmazie 58: 932-934.
3. Al-Shabanah OA. 1993. Inhibition of adriamycin-induced micronuclei by desferrioxamine in Swiss albino mice. Mutat Res 301: 107-111.
4. Antunes LM, Takahashi CS. 1998. Effects of high doses of vitamins C and E against doxorubicin-induced chromosomal damage in Wistar rat bone marrow cells. Mutat Res 419: 137-143.
5. Antunes LM, Takahashi CS. 1999. Protection and induction of chromosomal damage by vitamin C in human lymphocyte cultures. Teratog Carcinog Mutagen 19: 53-59.
6. Badr FM, El-Habit OHM, Hamdy M, Hassan GAR. 1998. The mutagenic versus protective role of vitamin A on the induction of chromosomal aberrations in human lymphocyte cultures. Mutat Res 414: 157-163.
7. Bean CL, Armstrong MJ, Galloway SM. 1992. Effect of sampling time on chromosome aberration yield for 7 chemicals in Chinese hamster ovary cells. Mutat Res 265: 31-44.
8. Cabrera G. 2000. Effect of five dietary antimutagens on the genotoxicity of six mutagens in the microscreen prophage induction assay. Environ Mol Mutagen 36: 206-220.
9. Countryman PI, Heddle JA. 1976. The production of micronuclei from chromosome aberrations in irradiated cultures of human lymphocytes. Mutat Res 41: 321-332.
10. DeAtley SM, Aksenov MY, Aksenova MV et al. 1999. Antioxidants protect against reactive oxygen species associated with doxorubicin-treated cardiomyocytes. Cancer Lett 136: 41-46.
11. Debasis B, Mnashi B, Sidney JS, Siddhartha DR, Chandan KS, Harry GP. 2002. Cellular protection with proanthocyanidins derived from grape seeds. Ann NY Acad Sci 957: 260-270.
12. Delvaeye M, Verovski V, De Neve W, Storme G. 1993. DNA breakage, cytotoxicity, drug accumulation and retention in two human ovarian tumor cell lines AZ224 and AZ364 treated with adriamycin, modulated by verapamil. Anticancer Res 13: 1533-1538.
13. Dulout FN, Larramendy ML, Olivero OA. 1981. Effect of caffeine on the frequency of chromosome aberrations induced in vivo by triethylenemelamine (TEM) and adriamycin (ADR) in mice. Mutat Res 82: 295-304.
14. Dwivedi S, Gupta D. 2002. Efficacy of Terminalia arjuna in chronic stable angina. Indian Heart J 54: 170-175.
15. El-Nahas SM, Mattar FE, Mohamed AA. 1993. Radioprotective effect of vitamins C and E. Mutat Res 301: 143-147.
16. Gewirtz DA. 1999. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics doxorubicin and daunorubicin. Biochem Pharmacol 57: 727-741.
17. Halliwell B. 1987. Oxidative damage, lipid peroxidation and antioxidant protection in chloroplasts. Chem Phys Lipids 44: 327-340.
18. Halliwell B, Gutteridge JMC. 1989. Free Radicals in Biology and Medicine, 2nd edn. Oxford University Press: New York, 543.
19. Hsiu-Chuan Y, Terry DO, Satit V, Ye-Shih H, Daret KSC. 1996. The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice. J Clin Invest 98: 1253-1260.
20. Hyland K, Voisin E, Banoun H, Auclair C. 1983. Superoxide dismutase assay using alkaline dimethylsulfoxide as superoxide anion-generating system. Anal Biochem 135: 280-287.
21. Jagetia GC, Aruna R. 2000. Correlation between cell survival and micronuclei-induction in HeLa cells treated with adriamycin after exposure to various doses of gamma-radiation. Toxicol Lett 115: 183-193.
22. Jagetia GC, Nayak V. 1996. Micronuclei-induction and its correlation to cell survival in HeLa cells treated with different doses of adriamycin. Cancer Lett 110: 123-128.
23. Jagetia GC, Nayak V. 2000. Effect of doxorubicin on cell survival and micronuclei formation in HeLa cells exposed to different doses of gamma-radiation. Strahlenther Onkol 176: 422-428.
24. Jagetia GC, Nayak V, Vidyasagar MS. 1998. Evaluation of the antineoplastic activity of guduchi (Tinospora cordifolia) in cultured HeLa cells. Cancer Lett 127: 71-82.
25. Jagetia GC, Venkatesh P, Baliga MS. 2003. Evaluation of the radioprotective effect of Aegle marmelos (L.) Correa in cultured human peripheral blood lymphocytes exposed to different doses of gamma-radiation: A micronucleus study. Mutagenesis 18: 387-393.
26. 2 by iron-adriamycin. J Biol Chem 259: 6056-6058.
27. Karimi G, Ramezani M, Abdi A. 2005. Protective effects of lycopene and tomato extract against doxorubicin-induced cardiotoxicity. Phytother Res 19: 912-914. DOI: 10.1002/ ptr.1746
28. Larramendy ML, Dulout FN, Bianchi NO, Olivero OA. 1980. In vivo dose-response relationship in bone-marrow cells of mice treated with adriamycin. Mutat Res 79: 133-140.
29. Mensor LL, Menezes FS, Leitao GG et al. 2001. Screening of Brazilian plant extracts for antioxidant activity by the use of DPPH free radical method. Phytother Res 15: 127-130.
30. Miller NJ, Rice-Evans C. 1996. Spectrophotometric determination of antioxidant activity. Redox Rep 2: 161-171.
31. Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L. 2004. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 56: 185-229.
32. Myers C. 1998. The role of iron in doxorubicin-induced cardiomyopathy. Semin Oncol 25: 10-14.
33. Myers CE, McGuire WP, Liss RH, Ifrim I, Grotzinger K, Young RC. 1977. Doxorubicin: the role of lipid peroxidation in cardiac toxicity and tumor response. Science 197: 165-167.
34. Myers CE, Mimnaugh EG, Yeh GC, Sinha BK. 1988. In Anthracyclines and Anthracenedione-based Anticancer Agents, Lown JW (ed.). Elsevier: Amsterdam, 527-570.
35. Nandkarni AK. 1976. In Indian Materia Medica, Nandkarni AK, Nandkarni KM (eds). Popular Prakashan Private Ltd: Mumbai, Vol. 1, 1199-1202.
36. Neri GC, Neri B, Bandinelli M, Tacca MD, Danesi R, Riccardi R. 1991. Anthracycline cardiotoxicity: in vivo and in vitro effects on biochemical parameters and heart ultrastructure of the rat. Oncology 48: 327-333.
37. Nesamony S. 1988. Ovshadhya Sasyangai (Medicinal Plants). State Institute for Language: Kerala, India, 314-316.
38. Olson RD, Mushlin PS. 1990. Doxorubicin cardiotoxicity: analysis of prevailing hypotheses. FASEB J 4: 3076-3086.
39. Pawar RS, Bhutani KK. 2005. Effect of oleanane triterpenoids from Terminalia arjuna - a cardioprotective drug on the process of respiratory oxyburst. Phytomedicine 12: 391-393.
40. Powis G. 1989. Free radical formation by antitumor quinones. Free Radic Biol Med 6: 63-101.
41. Psotová J, Chlopcikova S, Miketová P, Simánek V. 2005. Cytoprotectivity of Prunella vulgaris on doxorubicin-treated rat cardiomyocytes. Fitoterapia 76: 556-561.
42. Weiss RB. 1992. The anthracyclines: will we ever find a better doxorubicin. Semin Oncol 19: 670-686.
43. You JS, Huang HF, Chang YL. 2005. Panax ginseng reduces adriamycin-induced heart failure in rats. Phytother Res 19: 1018-1022. DOI: 10.1002/ptr.1778
44. Zweier JL. 1985. Iron-mediated formation of an oxidized doxorubicin free radical. Biochim Biophys Acta 839: 209-213.